Luc Biedermann Selected Research

alicaforsen

1/2018	Alicaforsen, an Antisense Inhibitor of Intercellular Adhesion Molecule-1, in the Treatment for Left-Sided Ulcerative Colitis and Ulcerative Proctitis.
2/2016	Alicaforsen, an antisense inhibitor of ICAM-1, as treatment for chronic refractory pouchitis after proctocolectomy: A case series.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Luc Biedermann Research Topics

Disease

28	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 01/2022 - 01/2012
22	Ulcerative Colitis 01/2022 - 01/2012
22	Crohn Disease (Crohn's Disease) 01/2022 - 01/2012
10	Eosinophilic Esophagitis 01/2022 - 10/2017
6	Inflammation (Inflammations) 01/2020 - 01/2018
5	Fistula 01/2022 - 01/2014
5	Infections 01/2021 - 02/2013
5	Colitis 01/2021 - 01/2014
4	Pathologic Constriction (Stenosis) 01/2022 - 01/2017
4	Neoplasms (Cancer) 01/2021 - 01/2016
3	Necrosis 01/2021 - 01/2016
3	Celiac Disease (Celiac Sprue) 01/2021 - 07/2016
3	Osteoporosis 09/2019 - 06/2017
3	Pain (Aches) 09/2019 - 01/2016
3	Malabsorption Syndromes (Malabsorption Syndrome) 12/2018 - 01/2016
2	Carcinoma (Carcinomatosis) 01/2021 - 01/2014
2	Hemorrhage 08/2018 - 12/2013
2	Gastrointestinal Diseases (Functional Gastrointestinal Disorders) 08/2018 - 08/2015
2	Psoriasis (Pustulosis Palmaris et Plantaris) 02/2018 - 01/2014
2	Clostridium Infections 01/2016 - 01/2013
1	Clinical Deterioration 01/2022
1	Meningitis 01/2022
1	Flushing 02/2021
1	Abdominal Pain (Pain, Abdominal) 02/2021
1	Genetic Predisposition to Disease (Genetic Predisposition) 01/2021
1	Fournier Gangrene 01/2020
1	Metabolic Bone Diseases (Osteopenia) 09/2019
1	Uveitis 01/2019
1	Intestinal Diseases (Diseases, Intestinal) 01/2019
1	Eosinophilic enteropathy 01/2019

Drug/Important Bio-Agent (IBA)

13	SteroidsIBA 01/2022 - 01/2012
7	Adrenal Cortex Hormones (Corticosteroids)IBA 12/2021 - 05/2016
6	AntibodiesIBA 02/2021 - 01/2014
5	Anti-Bacterial Agents (Antibiotics)IBA 01/2021 - 01/2013
5	Immunologic Factors (Immunomodulators)IBA 01/2021 - 09/2014
5	CytokinesIBA 01/2017 - 01/2012
4	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2022 - 01/2012
3	Pharmaceutical PreparationsIBA 02/2021 - 02/2016
3	vedolizumabIBA 01/2021 - 10/2018
3	Immune Checkpoint InhibitorsIBA 01/2021 - 01/2020
3	Glutens (Glutelin)IBA 01/2021 - 07/2016
3	Proteins (Proteins, Gene)FDA Link 01/2016 - 01/2016
3	Azathioprine (Imuran)FDA LinkGeneric 01/2016 - 02/2013
3	2-mercaptopurineIBA 01/2016 - 02/2013
2	Tumor Necrosis Factor InhibitorsIBA 01/2022 - 01/2015
2	Biological ProductsIBA 01/2022 - 01/2014
2	golimumab FDA Link 01/2022 - 11/2017
2	Metronidazole (Metric)FDA LinkGeneric 02/2021 - 09/2017
2	Doxycycline (Periostat)FDA LinkGeneric 02/2021 - 09/2017
2	AllergensIBA 01/2021 - 12/2018
2	Leukocyte L1 Antigen Complex (Calgranulin)IBA 12/2020 - 08/2018
2	Proton Pump InhibitorsIBA 01/2020 - 03/2018
2	Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA 09/2019 - 01/2017
2	Calcineurin InhibitorsIBA 01/2019 - 07/2017
2	alicaforsenIBA 01/2018 - 02/2016
2	Non-Receptor Type 2 Protein Tyrosine PhosphataseIBA 01/2018 - 01/2016
2	Antisense OligonucleotidesIBA 01/2018 - 02/2016
2	Intercellular Adhesion Molecule-1 (Intercellular Adhesion Molecule 1)IBA 01/2018 - 02/2016
2	Coffee FDA Link 05/2017 - 08/2015
2	Certolizumab Pegol FDA Link 01/2017 - 01/2014
2	Biomarkers (Surrogate Marker)IBA 07/2015 - 01/2015
2	Adalimumab (Humira)FDA Link 01/2015 - 01/2014
1	4-amino-4'-hydroxylaminodiphenylsulfone (HADS)IBA 01/2022
1	Genetic Markers (Genetic Marker)IBA 01/2022
1	NLR ProteinsIBA 08/2021
1	Dihydrotachysterol (AT 10)IBA 02/2021
1	Ciprofloxacin (Cipro)FDA LinkGeneric 02/2021
1	Acetylcysteine (Siran)FDA LinkGeneric 02/2021
1	Fibrin Tissue Adhesive (Fibrin Sealant)IBA 02/2021
1	Glutamine (L-Glutamine)FDA Link 01/2021
1	Peptides (Polypeptides)IBA 01/2021
1	ZED1227IBA 01/2021
1	SuspensionsIBA 01/2021
1	NivolumabIBA 01/2021
1	Phenobarbital (Luminal)FDA Link 01/2021
1	Tacrolimus (Prograf)FDA LinkGeneric 01/2021
1	Protein Glutamine gamma Glutamyltransferase 2IBA 01/2021
1	IpilimumabIBA 01/2021
1	Monoclonal AntibodiesIBA 01/2021
1	TabletsIBA 11/2020
1	Budesonide (Pulmicort)FDA LinkGeneric 11/2020
1	tofacitinibIBA 06/2020
1	Janus Kinase InhibitorsIBA 06/2020
1	Indicators and Reagents (Reagents)IBA 01/2019
1	AcidsIBA 12/2018
1	VitaminsIBA 12/2018
1	Vitamin B 12 (Cyanocobalamin)FDA LinkGeneric 12/2018

Therapy/Procedure

24	Therapeutics 01/2022 - 01/2012
3	Colectomy 01/2021 - 04/2018
3	Aftercare (After-Treatment) 01/2021 - 01/2018
2	Ileostomy 01/2021 - 01/2020
2	Fecal Microbiota Transplantation 03/2017 - 01/2016
1	Sutures (Suture) 02/2021
1	Antibiotic Prophylaxis 02/2021
1	Curettage 02/2021
1	Duration of Therapy 01/2021
1	Drug Therapy (Chemotherapy) 11/2020
1	Cesarean Section (Caesarean Section) 11/2020
1	Conservative Treatment 01/2020
1	Gluten-Free Diet 01/2019